The 192R/Q polymorphs of serum paraoxonase PON1 differ in HDL binding, lipolactonase stimulation, and cholesterol efflux
Open Access
- 1 November 2006
- journal article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 47 (11), 2492-2502
- https://doi.org/10.1194/jlr.m600297-jlr200
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Low Paraoxonase Activity Predicts Coronary Events in the Caerphilly Prospective StudyCirculation, 2003
- Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout miceFree Radical Biology & Medicine, 2003
- AtherosclerosisNature, 2000
- Human Serum Paraoxonases (PON1) Q and R Selectively Decrease Lipid Peroxides in Human Coronary and Carotid Atherosclerotic LesionsCirculation, 2000
- Does paraoxonase play a role in susceptibility to cardiovascular disease?Molecular Medicine Today, 1999
- Paraoxonase Active Site Required for Protection Against LDL Oxidation Involves Its Free Sulfhydryl Group and Is Different From That Required for Its Arylesterase/Paraoxonase ActivitiesArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosisNature, 1998
- The Human Serum Paraoxonase/Arylesterase Gene (PON1) Is One Member of a Multigene FamilyGenomics, 1996
- Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.JCI Insight, 1995
- Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonaseAtherosclerosis, 1993